| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 4.23e-08 | 11 | 69 | 4 | GO:0016303 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 3-kinase activity | 1.37e-06 | 7 | 69 | 3 | GO:0035005 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity | 1.37e-06 | 7 | 69 | 3 | GO:0046934 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 1.84e-06 | 26 | 69 | 4 | GO:0052742 | |
| GeneOntologyMolecularFunction | hydroxymethylglutaryl-CoA lyase activity | 1.18e-05 | 2 | 69 | 2 | GO:0004419 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 1.20e-05 | 41 | 69 | 4 | GO:0001727 | |
| GeneOntologyMolecularFunction | calcium ion binding | SNED1 THBS2 FAT1 NRXN1 PAMR1 SUSD1 TTYH2 PLA2G2F ATP2A2 NOTCH2 | 2.39e-04 | 749 | 69 | 10 | GO:0005509 |
| GeneOntologyMolecularFunction | oxo-acid-lyase activity | 2.44e-04 | 7 | 69 | 2 | GO:0016833 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-3-phosphate biosynthetic process | 7.56e-07 | 22 | 68 | 4 | GO:0036092 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 6.60e-05 | 24 | 68 | 3 | GO:0048015 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol phosphate biosynthetic process | 6.68e-05 | 66 | 68 | 4 | GO:0046854 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class I | 2.85e-06 | 9 | 69 | 3 | GO:0097651 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class IA | 2.85e-06 | 9 | 69 | 3 | GO:0005943 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class IB | 6.42e-05 | 4 | 69 | 2 | GO:0005944 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex | 1.18e-04 | 29 | 69 | 3 | GO:0005942 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 9.79e-04 | 230 | 69 | 5 | GO:0019898 | |
| GeneOntologyCellularComponent | mitochondrial outer membrane | 1.20e-03 | 241 | 69 | 5 | GO:0005741 | |
| Domain | EGF_1 | 2.25e-09 | 255 | 69 | 11 | PS00022 | |
| Domain | EGF-like_CS | 2.87e-09 | 261 | 69 | 11 | IPR013032 | |
| Domain | EGF_3 | 1.46e-08 | 235 | 69 | 10 | PS50026 | |
| Domain | EGF | 1.46e-08 | 235 | 69 | 10 | SM00181 | |
| Domain | EGF | 2.03e-08 | 126 | 69 | 8 | PF00008 | |
| Domain | EGF-like_dom | 2.53e-08 | 249 | 69 | 10 | IPR000742 | |
| Domain | EGF_2 | 4.55e-08 | 265 | 69 | 10 | PS01186 | |
| Domain | ARM-rpt_dom | 5.52e-08 | 11 | 69 | 4 | IPR006911 | |
| Domain | Arm_2 | 5.52e-08 | 11 | 69 | 4 | PF04826 | |
| Domain | Kelch | 7.09e-08 | 58 | 69 | 6 | SM00612 | |
| Domain | Gal_Oxase/kelch_b-propeller | 7.87e-08 | 59 | 69 | 6 | IPR011043 | |
| Domain | PI3K_ABD | 1.93e-07 | 4 | 69 | 3 | PS51544 | |
| Domain | PI3K_adapt-bd_dom | 1.93e-07 | 4 | 69 | 3 | IPR003113 | |
| Domain | Kelch_1 | 2.22e-07 | 70 | 69 | 6 | PF01344 | |
| Domain | Kelch_1 | 2.22e-07 | 70 | 69 | 6 | IPR006652 | |
| Domain | PI3/4_kinase_CS | 2.26e-07 | 15 | 69 | 4 | IPR018936 | |
| Domain | - | 3.00e-07 | 16 | 69 | 4 | 1.10.1070.11 | |
| Domain | PI3Kc | 3.00e-07 | 16 | 69 | 4 | SM00146 | |
| Domain | DMAP_binding | 4.80e-07 | 5 | 69 | 3 | PF06464 | |
| Domain | PI3/4_kinase_cat_dom | 5.02e-07 | 18 | 69 | 4 | IPR000403 | |
| Domain | PI3_PI4_kinase | 5.02e-07 | 18 | 69 | 4 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 5.02e-07 | 18 | 69 | 4 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 5.02e-07 | 18 | 69 | 4 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 5.02e-07 | 18 | 69 | 4 | PS00916 | |
| Domain | BTB-kelch_protein | 5.13e-07 | 43 | 69 | 5 | IPR017096 | |
| Domain | DMAP1-bd | 9.58e-07 | 6 | 69 | 3 | IPR010506 | |
| Domain | DMAP_binding | 9.58e-07 | 6 | 69 | 3 | SM01137 | |
| Domain | PI3K_Ras-bd_dom | 1.67e-06 | 7 | 69 | 3 | IPR000341 | |
| Domain | PI3K_rbd | 1.67e-06 | 7 | 69 | 3 | PF00794 | |
| Domain | PI3K_RBD | 1.67e-06 | 7 | 69 | 3 | PS51546 | |
| Domain | PI3K_rbd | 1.67e-06 | 7 | 69 | 3 | SM00144 | |
| Domain | Kelch-typ_b-propeller | 1.79e-06 | 55 | 69 | 5 | IPR015915 | |
| Domain | PI3K_C2_dom | 2.67e-06 | 8 | 69 | 3 | IPR002420 | |
| Domain | PI3K_C2 | 2.67e-06 | 8 | 69 | 3 | PF00792 | |
| Domain | PI3K_C2 | 2.67e-06 | 8 | 69 | 3 | PS51547 | |
| Domain | PI3K_C2 | 2.67e-06 | 8 | 69 | 3 | SM00142 | |
| Domain | BACK | 2.77e-06 | 60 | 69 | 5 | SM00875 | |
| Domain | BACK | 3.01e-06 | 61 | 69 | 5 | PF07707 | |
| Domain | BACK | 3.01e-06 | 61 | 69 | 5 | IPR011705 | |
| Domain | PI3Ka | 3.99e-06 | 9 | 69 | 3 | PF00613 | |
| Domain | - | 3.99e-06 | 9 | 69 | 3 | 1.25.40.70 | |
| Domain | PI3Ka | 3.99e-06 | 9 | 69 | 3 | SM00145 | |
| Domain | AMP-binding | 4.35e-06 | 30 | 69 | 4 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 4.35e-06 | 30 | 69 | 4 | IPR000873 | |
| Domain | PIK_HELICAL | 5.68e-06 | 10 | 69 | 3 | PS51545 | |
| Domain | PI_Kinase | 5.68e-06 | 10 | 69 | 3 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 5.68e-06 | 10 | 69 | 3 | IPR001263 | |
| Domain | EGF_CA | 5.88e-06 | 122 | 69 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 6.46e-06 | 124 | 69 | 6 | IPR001881 | |
| Domain | Gal_Oxidase_b-propeller | 7.28e-06 | 34 | 69 | 4 | IPR015916 | |
| Domain | BTB | 8.86e-06 | 131 | 69 | 6 | PF00651 | |
| Domain | HMG_COA_LYASE | 1.35e-05 | 2 | 69 | 2 | PS01062 | |
| Domain | BTB | 2.76e-05 | 160 | 69 | 6 | PS50097 | |
| Domain | ASX_HYDROXYL | 3.41e-05 | 100 | 69 | 5 | PS00010 | |
| Domain | PYR_CT | 4.03e-05 | 3 | 69 | 2 | IPR000891 | |
| Domain | HMGL-like | 4.03e-05 | 3 | 69 | 2 | PF00682 | |
| Domain | PI3K_p85B | 4.03e-05 | 3 | 69 | 2 | PF02192 | |
| Domain | PI3K_p85B | 4.03e-05 | 3 | 69 | 2 | SM00143 | |
| Domain | PYR_CT | 4.03e-05 | 3 | 69 | 2 | PS50991 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.51e-05 | 106 | 69 | 5 | IPR000152 | |
| Domain | BTB | 5.34e-05 | 180 | 69 | 6 | SM00225 | |
| Domain | BTB/POZ_dom | 6.22e-05 | 185 | 69 | 6 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 7.00e-05 | 189 | 69 | 6 | IPR011333 | |
| Domain | ARM-type_fold | 2.51e-04 | 339 | 69 | 7 | IPR016024 | |
| Domain | Yip1 | 2.79e-04 | 7 | 69 | 2 | PF04893 | |
| Domain | Yip1 | 2.79e-04 | 7 | 69 | 2 | IPR006977 | |
| Domain | EGF_CA | 2.88e-04 | 86 | 69 | 4 | PF07645 | |
| Domain | ARM_REPEAT | 4.32e-04 | 40 | 69 | 3 | PS50176 | |
| Domain | EGF_Ca-bd_CS | 4.56e-04 | 97 | 69 | 4 | IPR018097 | |
| Domain | EGF_CA | 4.93e-04 | 99 | 69 | 4 | PS01187 | |
| Domain | - | 7.41e-04 | 48 | 69 | 3 | 2.120.10.80 | |
| Domain | CCP | 1.05e-03 | 54 | 69 | 3 | SM00032 | |
| Domain | SUSHI | 1.16e-03 | 56 | 69 | 3 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.22e-03 | 57 | 69 | 3 | IPR000436 | |
| Domain | Laminin_G | 1.29e-03 | 58 | 69 | 3 | IPR001791 | |
| Domain | VWD | 1.56e-03 | 16 | 69 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.56e-03 | 16 | 69 | 2 | IPR001846 | |
| Domain | VWFD | 1.56e-03 | 16 | 69 | 2 | PS51233 | |
| Domain | VWD | 1.56e-03 | 16 | 69 | 2 | PF00094 | |
| Domain | LIM | 2.12e-03 | 69 | 69 | 3 | PF00412 | |
| Domain | - | 2.21e-03 | 70 | 69 | 3 | 2.10.110.10 | |
| Domain | Znf_LIM | 2.30e-03 | 71 | 69 | 3 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 2.30e-03 | 71 | 69 | 3 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 2.30e-03 | 71 | 69 | 3 | PS50023 | |
| Domain | LIM | 2.30e-03 | 71 | 69 | 3 | SM00132 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 5.54e-06 | 74 | 49 | 5 | M39857 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY | 6.39e-06 | 11 | 49 | 3 | M47756 | |
| Pathway | WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION | 8.49e-06 | 12 | 49 | 3 | M45559 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 8.49e-06 | 12 | 49 | 3 | M27905 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 8.49e-06 | 12 | 49 | 3 | MM15623 | |
| Pathway | KEGG_APOPTOSIS | 1.23e-05 | 87 | 49 | 5 | M8492 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 2.59e-05 | 17 | 49 | 3 | MM15584 | |
| Pathway | WP_FOCAL_ADHESION | 4.38e-05 | 187 | 49 | 6 | MM15913 | |
| Pathway | BIOCARTA_BAD_PATHWAY | 7.59e-05 | 24 | 49 | 3 | MM1467 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 7.67e-05 | 302 | 49 | 7 | M39719 | |
| Pathway | WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR | 8.60e-05 | 25 | 49 | 3 | M39794 | |
| Pathway | BIOCARTA_BAD_PATHWAY | 8.60e-05 | 25 | 49 | 3 | M85 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 8.60e-05 | 25 | 49 | 3 | M27865 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_LMP2A_TO_PI3K_SIGNALING_PATHWAY | 1.18e-04 | 5 | 49 | 2 | M48997 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_PI3K_SIGNALING_PATHWAY | 1.18e-04 | 5 | 49 | 2 | M49020 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.24e-04 | 326 | 49 | 7 | MM15917 | |
| Pathway | KEGG_VEGF_SIGNALING_PATHWAY | 1.38e-04 | 76 | 49 | 4 | M1749 | |
| Pathway | WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY | 1.50e-04 | 30 | 49 | 3 | M39592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 1.50e-04 | 30 | 49 | 3 | M47738 | |
| Pathway | KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY | 1.60e-04 | 79 | 49 | 4 | M11816 | |
| Pathway | REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS | 1.66e-04 | 31 | 49 | 3 | M46423 | |
| Pathway | REACTOME_CHOLINE_CATABOLISM | 1.76e-04 | 6 | 49 | 2 | MM15329 | |
| Pathway | REACTOME_CHOLINE_CATABOLISM | 1.76e-04 | 6 | 49 | 2 | M27619 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 1.93e-04 | 83 | 49 | 4 | M39637 | |
| Pathway | WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION | 2.00e-04 | 33 | 49 | 3 | M39745 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 2.03e-04 | 84 | 49 | 4 | M3228 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 2.32e-04 | 87 | 49 | 4 | M12467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LEUCINE_DEGRADATION | 2.46e-04 | 7 | 49 | 2 | M47633 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY | 2.46e-04 | 7 | 49 | 2 | M47790 | |
| Pathway | PID_ERBB4_PATHWAY | 3.06e-04 | 38 | 49 | 3 | M13 | |
| Pathway | REACTOME_SYNTHESIS_OF_KETONE_BODIES | 3.27e-04 | 8 | 49 | 2 | M27718 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 3.27e-04 | 8 | 49 | 2 | M47399 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 3.27e-04 | 8 | 49 | 2 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 3.27e-04 | 8 | 49 | 2 | M47395 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 3.27e-04 | 8 | 49 | 2 | M47404 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 3.27e-04 | 8 | 49 | 2 | M47405 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 3.27e-04 | 8 | 49 | 2 | M47803 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 3.27e-04 | 8 | 49 | 2 | M47482 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 3.27e-04 | 8 | 49 | 2 | M47498 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 3.27e-04 | 8 | 49 | 2 | M47715 | |
| Pathway | REACTOME_SYNTHESIS_OF_KETONE_BODIES | 3.27e-04 | 8 | 49 | 2 | MM15460 | |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 3.30e-04 | 39 | 49 | 3 | M39905 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT | 3.56e-04 | 40 | 49 | 3 | M39798 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 3.56e-04 | 40 | 49 | 3 | M39695 | |
| Pathway | PID_TCPTP_PATHWAY | 4.12e-04 | 42 | 49 | 3 | M91 | |
| Pathway | KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION | 4.12e-04 | 42 | 49 | 3 | M16473 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 4.20e-04 | 9 | 49 | 2 | M22029 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 4.20e-04 | 9 | 49 | 2 | M47397 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 4.20e-04 | 9 | 49 | 2 | MM1551 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 4.20e-04 | 9 | 49 | 2 | M47392 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 4.20e-04 | 9 | 49 | 2 | M47391 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY | 4.20e-04 | 9 | 49 | 2 | M47402 | |
| Pathway | KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY | 4.20e-04 | 9 | 49 | 2 | M47629 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 4.20e-04 | 9 | 49 | 2 | M47802 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 4.20e-04 | 9 | 49 | 2 | M47490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 4.20e-04 | 9 | 49 | 2 | M47481 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 4.42e-04 | 43 | 49 | 3 | M39788 | |
| Pathway | PID_ERBB2_ERBB3_PATHWAY | 4.73e-04 | 44 | 49 | 3 | M175 | |
| Pathway | SIG_CHEMOTAXIS | 5.05e-04 | 45 | 49 | 3 | M5193 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 5.23e-04 | 10 | 49 | 2 | M47400 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY | 5.23e-04 | 10 | 49 | 2 | M47401 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY | 5.23e-04 | 10 | 49 | 2 | M47615 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING | 5.23e-04 | 10 | 49 | 2 | M568 | |
| Pathway | REACTOME_KETONE_BODY_METABOLISM | 5.23e-04 | 10 | 49 | 2 | MM15437 | |
| Pathway | REACTOME_KETONE_BODY_METABOLISM | 5.23e-04 | 10 | 49 | 2 | M27706 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 5.39e-04 | 46 | 49 | 3 | M48317 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 5.39e-04 | 46 | 49 | 3 | MM15837 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT | 5.67e-04 | 110 | 49 | 4 | M39492 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 5.75e-04 | 47 | 49 | 3 | M19708 | |
| Pathway | PID_PI3KCI_PATHWAY | 6.12e-04 | 48 | 49 | 3 | M141 | |
| Pathway | KEGG_FOCAL_ADHESION | 6.14e-04 | 199 | 49 | 5 | M7253 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 6.38e-04 | 11 | 49 | 2 | M47797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 6.38e-04 | 11 | 49 | 2 | M47403 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 6.38e-04 | 11 | 49 | 2 | M47406 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 6.38e-04 | 11 | 49 | 2 | M47484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 6.38e-04 | 11 | 49 | 2 | M47499 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339 | 6.38e-04 | 11 | 49 | 2 | M47791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 6.38e-04 | 11 | 49 | 2 | M47501 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 6.50e-04 | 49 | 49 | 3 | MM1442 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 6.50e-04 | 49 | 49 | 3 | M40046 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 6.90e-04 | 50 | 49 | 3 | MM14641 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 7.31e-04 | 51 | 49 | 3 | M2288 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 7.39e-04 | 118 | 49 | 4 | M39852 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 7.64e-04 | 12 | 49 | 2 | M47393 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350 | 7.64e-04 | 12 | 49 | 2 | M47798 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 7.64e-04 | 12 | 49 | 2 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 7.64e-04 | 12 | 49 | 2 | M47559 | |
| Pathway | KEGG_ENDOMETRIAL_CANCER | 7.74e-04 | 52 | 49 | 3 | M19877 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 7.74e-04 | 52 | 49 | 3 | M2404 | |
| Pathway | KEGG_MTOR_SIGNALING_PATHWAY | 7.74e-04 | 52 | 49 | 3 | M7561 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 8.18e-04 | 53 | 49 | 3 | M662 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 8.35e-04 | 213 | 49 | 5 | M18306 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 8.64e-04 | 54 | 49 | 3 | M3896 | |
| Pathway | KEGG_NON_SMALL_CELL_LUNG_CANCER | 8.64e-04 | 54 | 49 | 3 | M19818 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 9.01e-04 | 13 | 49 | 2 | M47398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 9.01e-04 | 13 | 49 | 2 | M47603 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 1.01e-03 | 57 | 49 | 3 | M19888 | |
| Pathway | BIOCARTA_ACH_PATHWAY | 1.05e-03 | 14 | 49 | 2 | M16884 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 1.05e-03 | 14 | 49 | 2 | M47390 | |
| Pathway | BIOCARTA_ERK5_PATHWAY | 1.05e-03 | 14 | 49 | 2 | MM1481 | |
| Pubmed | 7.51e-11 | 5 | 70 | 4 | 22084313 | ||
| Pubmed | 4.91e-09 | 11 | 70 | 4 | 22569362 | ||
| Pubmed | 7.81e-09 | 3 | 70 | 3 | 17236128 | ||
| Pubmed | Class IA PI3Ks regulate subcellular and functional dynamics of IDO1. | 7.81e-09 | 3 | 70 | 3 | 33159421 | |
| Pubmed | Loss of Phosphatidylinositol 3-Kinase Activity in Regulatory T Cells Leads to Neuronal Inflammation. | 3.12e-08 | 4 | 70 | 3 | 32414808 | |
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 17920279 | ||
| Pubmed | PI 3-kinase p110beta: a new target for antithrombotic therapy. | 3.12e-08 | 4 | 70 | 3 | 15834429 | |
| Pubmed | Activity of any class IA PI3K isoform can sustain cell proliferation and survival. | 3.12e-08 | 4 | 70 | 3 | 20534549 | |
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 23029326 | ||
| Pubmed | 3.51e-08 | 17 | 70 | 4 | 25327288 | ||
| Pubmed | TRPM7 ion channels are required for sustained phosphoinositide 3-kinase signaling in lymphocytes. | 7.79e-08 | 5 | 70 | 3 | 18590694 | |
| Pubmed | Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion. | 1.55e-07 | 6 | 70 | 3 | 22972933 | |
| Pubmed | 6.50e-07 | 9 | 70 | 3 | 18367611 | ||
| Pubmed | 6.50e-07 | 9 | 70 | 3 | 21765914 | ||
| Pubmed | 9.28e-07 | 10 | 70 | 3 | 9113989 | ||
| Pubmed | 9.28e-07 | 10 | 70 | 3 | 8798481 | ||
| Pubmed | Expression of HIV-1 nef decreases basal phosphatidyl-inositol 3-kinase activity. | 9.28e-07 | 10 | 70 | 3 | 9247029 | |
| Pubmed | The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1. | 9.28e-07 | 10 | 70 | 3 | 8636073 | |
| Pubmed | 1.27e-06 | 11 | 70 | 3 | 23077641 | ||
| Pubmed | 1.27e-06 | 11 | 70 | 3 | 16081599 | ||
| Pubmed | Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells. | 1.27e-06 | 11 | 70 | 3 | 12584329 | |
| Pubmed | 1.27e-06 | 11 | 70 | 3 | 9808187 | ||
| Pubmed | 1.27e-06 | 11 | 70 | 3 | 9708406 | ||
| Pubmed | 1.27e-06 | 11 | 70 | 3 | 10985305 | ||
| Pubmed | 1.27e-06 | 11 | 70 | 3 | 25104021 | ||
| Pubmed | 1.44e-06 | 41 | 70 | 4 | 23676014 | ||
| Pubmed | 1.70e-06 | 12 | 70 | 3 | 14602571 | ||
| Pubmed | 1.70e-06 | 12 | 70 | 3 | 16514418 | ||
| Pubmed | 1.70e-06 | 12 | 70 | 3 | 10208934 | ||
| Pubmed | 1.70e-06 | 12 | 70 | 3 | 12077252 | ||
| Pubmed | 1.70e-06 | 12 | 70 | 3 | 9341793 | ||
| Pubmed | 1.70e-06 | 12 | 70 | 3 | 12551992 | ||
| Pubmed | 2.20e-06 | 13 | 70 | 3 | 9394803 | ||
| Pubmed | 2.20e-06 | 13 | 70 | 3 | 23215766 | ||
| Pubmed | 2.80e-06 | 14 | 70 | 3 | 26075907 | ||
| Pubmed | 2.80e-06 | 14 | 70 | 3 | 26270987 | ||
| Pubmed | 2.80e-06 | 14 | 70 | 3 | 17157319 | ||
| Pubmed | Chemokine coreceptor signaling in HIV-1 infection and pathogenesis. | 2.80e-06 | 14 | 70 | 3 | 20041213 | |
| Pubmed | HIV Nef enhances Tat-mediated viral transcription through a hnRNP-K-nucleated signaling complex. | 3.49e-06 | 15 | 70 | 3 | 18854243 | |
| Pubmed | 3.49e-06 | 15 | 70 | 3 | 20702582 | ||
| Pubmed | PI3 kinase alpha and delta promote hematopoietic stem cell activation. | 3.99e-06 | 2 | 70 | 2 | 31120863 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19147653 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 31589839 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 12137943 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 15878979 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19297623 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 27442134 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23341541 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 22847177 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26431158 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16116162 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21188463 | ||
| Pubmed | Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinases. | 3.99e-06 | 2 | 70 | 2 | 15739165 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 8440722 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17971428 | ||
| Pubmed | A membrane protein enriched in endoplasmic reticulum exit sites interacts with COPII. | 3.99e-06 | 2 | 70 | 2 | 11489904 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 10330499 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 18250464 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16728507 | ||
| Pubmed | Biophysical and Structural Characterization of Novel RAS-Binding Domains (RBDs) of PI3Kα and PI3Kγ. | 3.99e-06 | 2 | 70 | 2 | 33539876 | |
| Pubmed | Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis. | 3.99e-06 | 2 | 70 | 2 | 24043760 | |
| Pubmed | PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? | 3.99e-06 | 2 | 70 | 2 | 17290298 | |
| Pubmed | PI3K/p110{delta} is a novel therapeutic target in multiple myeloma. | 3.99e-06 | 2 | 70 | 2 | 20505158 | |
| Pubmed | Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival. | 3.99e-06 | 2 | 70 | 2 | 16304053 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17626838 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26883061 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23142539 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 31691624 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19604150 | ||
| Pubmed | Role of PI3Kdelta and PI3Kgamma in inflammatory arthritis and tissue localization of neutrophils. | 3.99e-06 | 2 | 70 | 2 | 18412166 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 31216371 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 27154356 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17723215 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 30877223 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17644738 | ||
| Pubmed | 4.29e-06 | 16 | 70 | 3 | 20019835 | ||
| Pubmed | 4.29e-06 | 16 | 70 | 3 | 21029719 | ||
| Pubmed | 4.29e-06 | 16 | 70 | 3 | 20818790 | ||
| Pubmed | HIV-1 gp120-mediated apoptosis of T cells is regulated by the membrane tyrosine phosphatase CD45. | 4.29e-06 | 16 | 70 | 3 | 16524887 | |
| Pubmed | 4.29e-06 | 16 | 70 | 3 | 11289809 | ||
| Pubmed | Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages. | 5.20e-06 | 17 | 70 | 3 | 18453587 | |
| Pubmed | 5.20e-06 | 17 | 70 | 3 | 23251686 | ||
| Pubmed | Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways. | 5.20e-06 | 17 | 70 | 3 | 12960231 | |
| Pubmed | 5.48e-06 | 57 | 70 | 4 | 34878901 | ||
| Pubmed | HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. | 6.23e-06 | 18 | 70 | 3 | 12526811 | |
| Pubmed | 7.39e-06 | 19 | 70 | 3 | 24073214 | ||
| Pubmed | 1.01e-05 | 21 | 70 | 3 | 9446795 | ||
| Pubmed | Notch signaling maintains Leydig progenitor cells in the mouse testis. | 1.01e-05 | 21 | 70 | 3 | 18927153 | |
| Pubmed | 1.17e-05 | 22 | 70 | 3 | 11994280 | ||
| Pubmed | Cbln1 regulates axon growth and guidance in multiple neural regions. | 1.17e-05 | 22 | 70 | 3 | 36395107 | |
| Pubmed | 1.17e-05 | 22 | 70 | 3 | 11154208 | ||
| Pubmed | Common genetic polymorphisms affect the human requirement for the nutrient choline. | 1.20e-05 | 3 | 70 | 2 | 16816108 | |
| Pubmed | The role of endothelial PI3Kgamma activity in neutrophil trafficking. | 1.20e-05 | 3 | 70 | 2 | 15769890 | |
| Pubmed | CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway. | 1.20e-05 | 3 | 70 | 2 | 19451552 | |
| Pubmed | PI3K accelerates, but is not required for, neutrophil chemotaxis to fMLP. | 1.20e-05 | 3 | 70 | 2 | 18187452 | |
| Pubmed | PI3Kβ plays a critical role in neutrophil activation by immune complexes. | 1.20e-05 | 3 | 70 | 2 | 21487106 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 11162520 | ||
| Pubmed | Identification of a second Grb2 binding site in the v-Fms tyrosine kinase. | 1.20e-05 | 3 | 70 | 2 | 9380408 | |
| Pubmed | hDKIR, a human homologue of the Drosophila kelch protein, involved in a ring-like structure. | 1.20e-05 | 3 | 70 | 2 | 15383316 | |
| Pubmed | Isoform-specific phosphoinositide 3-kinase inhibitors exert distinct effects in solid tumors. | 1.20e-05 | 3 | 70 | 2 | 20103642 | |
| Interaction | VEGFB interactions | 4.80e-06 | 34 | 67 | 4 | int:VEGFB | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 3.61e-04 | 219 | 70 | 4 | chr7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 6.11e-04 | 681 | 70 | 6 | chr1p36 | |
| Cytoband | 7q22 | 1.55e-03 | 38 | 70 | 2 | 7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq22 | 2.35e-03 | 172 | 70 | 3 | chrXq22 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 1.04e-06 | 8 | 49 | 3 | 831 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.59e-06 | 134 | 49 | 6 | 861 | |
| GeneFamily | Kelch like|BTB domain containing | 4.94e-06 | 42 | 49 | 4 | 617 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.44e-06 | 43 | 49 | 4 | 409 | |
| GeneFamily | Yip1 domain containing | 1.50e-04 | 7 | 49 | 2 | 105 | |
| GeneFamily | LIM class homeoboxes | 4.67e-04 | 12 | 49 | 2 | 522 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.94e-04 | 57 | 49 | 3 | 1179 | |
| GeneFamily | Solute carriers | 4.20e-03 | 395 | 49 | 5 | 752 | |
| GeneFamily | Fibronectin type III domain containing | 9.30e-03 | 160 | 49 | 3 | 555 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 8.08e-06 | 180 | 69 | 6 | M8239 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 1.51e-06 | 356 | 66 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 1.67e-05 | 364 | 66 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | FAT1 FN1 KLHL23 ARMCX6 PRKAR2B LIX1L SLC6A15 NR5A1 ARMCX3 NOTCH2 LHX9 | 2.39e-05 | 773 | 66 | 11 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.49e-07 | 190 | 70 | 6 | 979b1476fd2692fde977ce56257315fcfc8a01d5 | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.23e-06 | 165 | 70 | 5 | 66f0364098d82629aa2ec1dfe0c5ad23de7c2c12 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.00e-06 | 169 | 70 | 5 | 7c994653b0d629dfb046755d6b678452de0a15d2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.29e-06 | 175 | 70 | 5 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.76e-06 | 181 | 70 | 5 | 274c0b768925cd5804483303f8c5ebd17a534c41 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.00e-05 | 182 | 70 | 5 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.20e-05 | 189 | 70 | 5 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 189 | 70 | 5 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 189 | 70 | 5 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 189 | 70 | 5 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-05 | 190 | 70 | 5 | 7e4d80a3a7f83b6a50f1d0fe82fb6c242c39d5b0 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-05 | 190 | 70 | 5 | 106862ef44fcaa0971c3ba0147d13eb08015ca77 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.30e-05 | 192 | 70 | 5 | 4ed5040594ba2d0639f0990697504ecef872ca70 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.30e-05 | 192 | 70 | 5 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.30e-05 | 192 | 70 | 5 | 063e119c4b58957643908f667e6cfd6f7517fd03 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.36e-05 | 194 | 70 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.40e-05 | 195 | 70 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 1.43e-05 | 196 | 70 | 5 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | Healthy/Control-Non-classical_Monocyte|World / Disease group and Cell class | 1.47e-05 | 197 | 70 | 5 | 470784932e1fc3ff69f27cd83f56d85b0c01af63 | |
| ToppCell | E16.5-samps-Myeloid-Fetal_macrophage-macrophage_-_intermediate_-_unactivated|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.17e-05 | 150 | 70 | 4 | 60fdd266aaca1b589b9a77465a4a7fad4921339a | |
| ToppCell | droplet-Lung-nan-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 151 | 70 | 4 | c743dc8758416a4f562d60c8fd2df7e659ab6951 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 9.65e-05 | 152 | 70 | 4 | fc9472bc19f997103da535b035105f01429cb08e | |
| ToppCell | E16.5-samps-Myeloid-Fetal_macrophage-Proliferative_Myeloid|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.65e-05 | 152 | 70 | 4 | e427758a6e39052616a0d8ecec0c1299e81d1d3c | |
| ToppCell | E16.5-samps-Myeloid-Fetal_macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.90e-05 | 153 | 70 | 4 | e9567966fe4426176e2f2dc0be4832c769c9903a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-04 | 155 | 70 | 4 | 9d53caee196b5c2bbc90c4f54f693b64d4086065 | |
| ToppCell | E16.5-samps-Myeloid|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.07e-04 | 156 | 70 | 4 | c7c73cef5700b0ae75280e62c94728434c712537 | |
| ToppCell | droplet-Fat-Scat-21m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 158 | 70 | 4 | c8df636412a08c570f235c34d4cff46924a9b11d | |
| ToppCell | droplet-Fat-Scat-21m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 158 | 70 | 4 | 718eafcf8a171bb69b402dc9d69564c3521a62a9 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.23e-04 | 162 | 70 | 4 | 60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed | |
| ToppCell | E18.5-samps-Myeloid|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.23e-04 | 162 | 70 | 4 | 18e4a807e25f754a69e9eaaddfde40f8de9b8512 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.23e-04 | 162 | 70 | 4 | 0970e4eda60e3f015335e2726e6d565fb2f43372 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 163 | 70 | 4 | 4af92b211d12c5b88b65bb746242cd702b545bd0 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 163 | 70 | 4 | d24774e0aa612322c22fdb3b314aef275fa01d68 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 167 | 70 | 4 | 991a93e1075d562b7391f0689b2f62c1351d48d1 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 167 | 70 | 4 | 3dfec2fcc36caa6e394efae5e540a6fa28759977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 167 | 70 | 4 | 95b3b5ba3414729f0460a26a0deca48de0cbe33e | |
| ToppCell | facs-Kidney-nan-3m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 167 | 70 | 4 | f22d1471c785b30d096ec5cdc68974e850ed7de0 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 167 | 70 | 4 | d1a13d6ada572d8ddb2da95e6e122d2b705fad7f | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 167 | 70 | 4 | 9480739587d51e67a281778b9bddd7b5ffc3ad92 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 167 | 70 | 4 | 934905aeaafbc215ec8f6a7903498b0e258b9220 | |
| ToppCell | facs-Heart-RV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 168 | 70 | 4 | 8ee57814c7e9d45444f48b6b269c4d535bc4d5e1 | |
| ToppCell | facs-Heart-RV-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 168 | 70 | 4 | c1a5f4f4d32a1f8583048db709a7037cc9357ad8 | |
| ToppCell | facs-Heart-RV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 168 | 70 | 4 | a405f0de70293f68b4e000c1fc8a9ad33d56539a | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-04 | 168 | 70 | 4 | c3d2d573f21350a4a674faff30b06ff644d00ac3 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-04 | 170 | 70 | 4 | 1f994b690e881106a5d54b3080ccce6260bc3ac5 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 171 | 70 | 4 | 2594ba8236a69461d9786ffcd882c39d0c9d5788 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 171 | 70 | 4 | 79b806194df645cccd357520eb6801ab1e93b3c5 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 173 | 70 | 4 | e4eb2ac2cee16bfa8eabc938f8030ee161c972c5 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 173 | 70 | 4 | 371515471459307a3b2adce735263b4aac828956 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-macrophage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 173 | 70 | 4 | 4e9b6c71030ae0d63d54e7255e4a10b25970fcc4 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_T_(gd)|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.59e-04 | 173 | 70 | 4 | 62f2f42f54c9c6941bf888956be40230f92c883e | |
| ToppCell | facs-Heart-LA-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 174 | 70 | 4 | 30c083fe4711735e83dccfd00fcd746ae673d353 | |
| ToppCell | facs-Heart-LA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 174 | 70 | 4 | 46d19c1144fff19be682b7ba59d4c3e014f79e15 | |
| ToppCell | facs-Heart-LA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 174 | 70 | 4 | 1802a52552256d1e25d8b328ba62dcfe41671900 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.62e-04 | 174 | 70 | 4 | d67fc8e30cc67fff8f7fdeaccb409d12ca0992c1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 174 | 70 | 4 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 174 | 70 | 4 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | (03)_Secretory-(0)_uninjured|(03)_Secretory / shred by cell type and Timepoint | 1.62e-04 | 174 | 70 | 4 | ebdddb5091afcc49ab533c890f260f709880c5f9 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.66e-04 | 175 | 70 | 4 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.66e-04 | 175 | 70 | 4 | 22fd7d9b4d403cc8061316855f78bad0eb705ce9 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.66e-04 | 175 | 70 | 4 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | (03)_Secretory|World / shred by cell type and Timepoint | 1.70e-04 | 176 | 70 | 4 | cb7b1945788196ca79007f0768b6576ec885a0e5 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-04 | 176 | 70 | 4 | e2b59a904c5c8f9c88e1e63788e9b6485f22edd0 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-04 | 176 | 70 | 4 | f931192e3cc65414e2245354f443473696cc7ce8 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-pDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-04 | 179 | 70 | 4 | bbd4f8e988ef3f343aaedbc992b70f2bb6aff5f6 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.85e-04 | 180 | 70 | 4 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 180 | 70 | 4 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 180 | 70 | 4 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.85e-04 | 180 | 70 | 4 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.85e-04 | 180 | 70 | 4 | 0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 181 | 70 | 4 | 1db1eb7d330a7e5090994007ae287e11f0a74450 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 181 | 70 | 4 | 06174ce9240c9261c0f51a1b0d875335d60722e5 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.01e-04 | 184 | 70 | 4 | c451acfcd8fe28c1f4b1ea334b1129fa84a15c42 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.01e-04 | 184 | 70 | 4 | 8fa30789c9d583188667cf375d2218e392dd40bc | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 185 | 70 | 4 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.05e-04 | 185 | 70 | 4 | 3b77bc49cd3740acc025e162a36282ac09e12198 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.05e-04 | 185 | 70 | 4 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.05e-04 | 185 | 70 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.05e-04 | 185 | 70 | 4 | 4bee178ede12f56ba5f5bec44a03dc2a62c50137 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 185 | 70 | 4 | fd1911b57927c03470f9387962ca9581e5643fb3 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 185 | 70 | 4 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 185 | 70 | 4 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.05e-04 | 185 | 70 | 4 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | facs-Large_Intestine-Distal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 185 | 70 | 4 | 7a18d525de6f874924bfc61b9666b307da86421a | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.05e-04 | 185 | 70 | 4 | b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 73 | 70 | 3 | 3ac392ac46ad577c7d2c2b5e6a0a96ceb613097b | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 73 | 70 | 3 | 1bd6ff9659efc43b0a596da50e325bde2f0ba8f7 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.10e-04 | 186 | 70 | 4 | fc0b488c201a32d829047b58460297df2818b45d | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.10e-04 | 186 | 70 | 4 | db9b67066fc003c7995ec205d15176bf40c97add | |
| ToppCell | NS-moderate-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.14e-04 | 187 | 70 | 4 | fcc32dbc9c5ae6176f154715a3e73aa32d78ad64 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 187 | 70 | 4 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 187 | 70 | 4 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.14e-04 | 187 | 70 | 4 | 6981b856187a2e689260ecb7d0a1193a374ee9b9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.14e-04 | 187 | 70 | 4 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-04 | 188 | 70 | 4 | 72a1ee136d77c77e44793a512f60b5f7815a073a | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-04 | 188 | 70 | 4 | ecbba19eebba21b986caa99de78ea4245fde3600 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-04 | 188 | 70 | 4 | 0d7296ad26e97ad91c6927a6cfe4e6e70a74c5a6 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.18e-04 | 188 | 70 | 4 | a906c29e3fda22eecfec3e5cac706c417bf2b7a4 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 188 | 70 | 4 | ab6fa1beff91584d9303c2a33735de89aae8d5cd | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.23e-04 | 189 | 70 | 4 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| Drug | ZSTK474 | 2.21e-06 | 9 | 69 | 3 | ctd:C510150 | |
| Drug | N-(6-(6-chloro-5-(4-fluorophenylsulfonamido)pyridin-3-yl)benzo(d)thiazol-2-yl)acetamide | 3.15e-06 | 10 | 69 | 3 | ctd:C558744 | |
| Drug | Ic 21 | 4.23e-06 | 36 | 69 | 4 | CID000231825 | |
| Drug | 2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE | 9.05e-06 | 2 | 69 | 2 | DB06831 | |
| Drug | halenaquinone | 9.47e-06 | 14 | 69 | 3 | CID000370346 | |
| Drug | 4-hydroxyisoleucine | 1.18e-05 | 15 | 69 | 3 | CID000354197 | |
| Drug | U-320 | 2.71e-05 | 3 | 69 | 2 | CID000077162 | |
| Drug | (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE | 2.71e-05 | 3 | 69 | 2 | DB08059 | |
| Drug | Pentamidine isethionate [140-64-7]; Up 200; 6.8uM; MCF7; HT_HG-U133A | 3.14e-05 | 199 | 69 | 6 | 2834_UP | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; MCF7; HT_HG-U133A | 3.14e-05 | 199 | 69 | 6 | 3333_UP | |
| Drug | MDL 27,032 | 3.41e-05 | 21 | 69 | 3 | CID000163812 | |
| Drug | SF-6,5 | 5.41e-05 | 4 | 69 | 2 | CID000126860 | |
| Drug | NVP-BKM120 | 5.41e-05 | 4 | 69 | 2 | ctd:C571178 | |
| Drug | Se-methylselenocysteine | 5.43e-05 | 68 | 69 | 4 | CID000114835 | |
| Drug | 2-cyano-3-phenylacrylic acid | 5.84e-05 | 25 | 69 | 3 | CID000070534 | |
| Drug | 3-O-methyl-D-glucose | 6.80e-05 | 72 | 69 | 4 | CID000008973 | |
| Drug | AC1L1H7K | 7.66e-05 | 144 | 69 | 5 | CID000004010 | |
| Disease | Diffuse Large B-Cell Lymphoma | 7.59e-06 | 55 | 67 | 4 | C0079744 | |
| Disease | Ventricular Dysfunction, Left | 4.35e-05 | 30 | 67 | 3 | C0242698 | |
| Disease | response to tamsulosin | 1.06e-04 | 7 | 67 | 2 | GO_1901905 | |
| Disease | Solid Neoplasm | 1.06e-04 | 7 | 67 | 2 | C0280100 | |
| Disease | infertility (implicated_via_orthology) | 1.06e-04 | 7 | 67 | 2 | DOID:5223 (implicated_via_orthology) | |
| Disease | Premature ovarian failure | 1.06e-04 | 7 | 67 | 2 | cv:C0085215 | |
| Disease | Glioblastoma Multiforme | 1.21e-04 | 111 | 67 | 4 | C1621958 | |
| Disease | colorectal cancer (is_implicated_in) | 1.69e-04 | 121 | 67 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | cancer (implicated_via_orthology) | 3.63e-04 | 268 | 67 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 5.23e-04 | 15 | 67 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 5.23e-04 | 15 | 67 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 5.23e-04 | 15 | 67 | 2 | C0154091 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 5.97e-04 | 16 | 67 | 2 | C0334634 | |
| Disease | Benign neoplasm of stomach | 6.76e-04 | 17 | 67 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 6.76e-04 | 17 | 67 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 6.76e-04 | 17 | 67 | 2 | C0154060 | |
| Disease | Carcinoma of bladder | 7.59e-04 | 18 | 67 | 2 | C0699885 | |
| Disease | Glioblastoma | 7.82e-04 | 79 | 67 | 3 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 9.35e-04 | 84 | 67 | 3 | C0334588 | |
| Disease | Autism Spectrum Disorders | 9.67e-04 | 85 | 67 | 3 | C1510586 | |
| Disease | Ovarian Failure, Premature | 1.04e-03 | 21 | 67 | 2 | C0085215 | |
| Disease | BREAST CANCER | 1.04e-03 | 21 | 67 | 2 | 114480 | |
| Disease | Stomach Carcinoma | 1.04e-03 | 21 | 67 | 2 | C0699791 | |
| Disease | Adenoid Cystic Carcinoma | 1.55e-03 | 100 | 67 | 3 | C0010606 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.59e-03 | 26 | 67 | 2 | DOID:234 (is_implicated_in) | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 1.72e-03 | 27 | 67 | 2 | C1112155 | |
| Disease | Malignant tumor of breast | 1.72e-03 | 27 | 67 | 2 | cv:C0006142 | |
| Disease | Breast neoplasm | 1.72e-03 | 27 | 67 | 2 | cv:C1458155 | |
| Disease | azoospermia (implicated_via_orthology) | 1.72e-03 | 27 | 67 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | Familial cancer of breast | 1.72e-03 | 27 | 67 | 2 | cv:C0346153 | |
| Disease | prostate carcinoma in situ (is_marker_for) | 1.85e-03 | 28 | 67 | 2 | DOID:8634 (is_marker_for) | |
| Disease | lung small cell carcinoma (is_implicated_in) | 1.85e-03 | 28 | 67 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 1.98e-03 | 29 | 67 | 2 | C1333990 | |
| Disease | nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence | 1.98e-03 | 29 | 67 | 2 | EFO_0004329, EFO_0005430, EFO_0005431, EFO_0005432, EFO_0008364, MONDO_0007079 | |
| Disease | Myocardial Failure | 2.03e-03 | 110 | 67 | 3 | C1959583 | |
| Disease | Congestive heart failure | 2.03e-03 | 110 | 67 | 3 | C0018802 | |
| Disease | Heart failure | 2.03e-03 | 110 | 67 | 3 | C0018801 | |
| Disease | Left-Sided Heart Failure | 2.03e-03 | 110 | 67 | 3 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 2.03e-03 | 110 | 67 | 3 | C0235527 | |
| Disease | Heart Decompensation | 2.03e-03 | 110 | 67 | 3 | C1961112 | |
| Disease | Breast Cancer, Familial | 2.12e-03 | 30 | 67 | 2 | C0346153 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| REAYNLGVRYIGGCC | 286 | Q93088 | |
| LGVRYIGGCCGFEPY | 291 | Q93088 | |
| GCRDNYVYCLDLLGG | 1081 | Q4L235 | |
| TAGLVIGAGACYCIY | 11 | Q9UH62 | |
| IGAGACYCIYRLTRG | 16 | Q9UH62 | |
| AAGLMIGAGACYCVY | 11 | Q7L4S7 | |
| IGAGACYCVYKLTIG | 16 | Q7L4S7 | |
| AAGLLLGAGACYCIY | 11 | Q8N2F6 | |
| LGAGACYCIYRLTRG | 16 | Q8N2F6 | |
| YSYVVVGAGSAGCVL | 41 | Q8NE62 | |
| LRYFTYGILFGCGCS | 196 | P36021 | |
| LYQCGYSTGACEPIG | 66 | P20702 | |
| CGLGVCVCYGAIYAL | 381 | Q9Y573 | |
| CVCYGAIYALGGWVG | 386 | Q9Y573 | |
| EFPVCGLYRIYGVCG | 36 | O60393 | |
| CLYGGTCVVDNGGFV | 4061 | Q14517 | |
| VDGLGTYRCSCPLGY | 1041 | Q04721 | |
| AYRAYSLVLAGLGCG | 201 | Q96G91 | |
| QGSYSFLVCGVIFGC | 461 | Q8N468 | |
| CAGCGGKISDRYYLL | 71 | Q9NQ69 | |
| GGVCYYIEGINQLSC | 356 | O14511 | |
| AAFYGCLYAGCIPVT | 1061 | Q9P265 | |
| VCCEGYIYAIGGDSV | 376 | Q8IY47 | |
| YVCYVTLPGGSCFGS | 136 | Q8IVB5 | |
| YQLAGVEAGYACFCG | 161 | Q8NCW0 | |
| ALCAGCGGKISDRYY | 51 | P50458 | |
| NRYVCDCSGTGYLGR | 696 | Q9ULB1 | |
| SAILSFVGYGCYCGL | 36 | Q9BZM2 | |
| CAGYCVATFILGIGD | 901 | P42336 | |
| QCGCRIYNLGTGTGY | 261 | Q14376 | |
| LLVGVLGCYCYMGVI | 721 | Q13315 | |
| ICCLYGVPSAYGVVT | 286 | P61221 | |
| YLAIGCYVGAATVGA | 836 | P16615 | |
| GGPVLVITEYCCYGD | 656 | P07333 | |
| FLGVCVCGAIYTGLF | 441 | Q9BYW1 | |
| LVVASGVIYCLGGYD | 421 | Q53G59 | |
| YHCAVTLGGCVYALG | 361 | Q8NBE8 | |
| ERTYLGNALVCTCYG | 66 | P02751 | |
| GCFYRLRVYCISDGG | 631 | Q9Y2H6 | |
| GLYLLCECDGTVCYG | 71 | Q9NQT6 | |
| IAAFYGCLYAGCVPI | 1041 | Q9Y2E4 | |
| GTYYIQVCALVRCGG | 451 | P43251 | |
| GVCVLHNCIYAAGGY | 511 | Q14145 | |
| IYVKCDGVGRCVGNY | 201 | P31323 | |
| PGVDLIAAFYGCLYC | 1051 | Q14689 | |
| GSYKCACLAGYTGQR | 256 | Q6UXH9 | |
| GYVSCALGCPYEGSI | 211 | Q8TB92 | |
| GGIGFASCVVCYFVA | 141 | Q9H2J7 | |
| CGDKVSGYHYGLLTC | 16 | Q13285 | |
| SYLYNKVIGCSGCGA | 221 | Q86X40 | |
| GYVSCALGCPYEGKI | 166 | P35914 | |
| YTCGSVGAALYEGLA | 251 | Q9HAZ2 | |
| CCLIYSLTGVYGFLT | 261 | A6NNN8 | |
| GAPARGCGLCVLYNY | 346 | O94819 | |
| GCGLCVLYNYLFVAG | 351 | O94819 | |
| TCVVIGYGSCLFLYV | 246 | Q8NGU2 | |
| YGVLFAVGLCAPIYC | 6 | Q86WD7 | |
| RVAGYLCLCSTGYEG | 771 | Q8TER0 | |
| AAGVVIGAGACYCVY | 11 | Q9P291 | |
| VALGGICGVLSCAYL | 286 | P51800 | |
| SCAGYCVATFVLGIG | 931 | P48736 | |
| ITVIYDGACQVCGLY | 1031 | Q8N2E2 | |
| FACTGIALGYGVCSV | 356 | Q9H1C4 | |
| AGLICCAAVGVGFYG | 96 | Q9BSA4 | |
| APACVLELGTYCGYS | 131 | Q8WZ04 | |
| GGFYCICLEGYRATN | 96 | Q6UWL2 | |
| TLSCAGYCVATYVLG | 876 | O00329 | |
| GVYDKGSLCGYVCAL | 291 | Q8IYM2 | |
| YVYGISAIGCLGMFC | 151 | Q969M3 | |
| YFGICIKCGLGIYGA | 221 | A6NIX2 | |
| LGVVACYSGIGNYAL | 831 | Q6PGP7 | |
| YKCECQTGYAGDGLI | 676 | P35442 | |
| SGVSYGCVASVLGYC | 196 | Q8N8F6 | |
| YYSAVGCLGCIVAGV | 506 | Q1EHB4 | |
| SIGGGAQYCPCLYIV | 36 | Q9NRD5 | |
| GVCGALFIGYCIYFD | 11 | Q15388 | |
| GCHPYAGTATCLVYG | 1146 | Q9Y493 |